Pentagon provides $20M boon for TBI biomarkers

Kathy Mahdoubi | | Health Imaging | Molecular Imaging

Abbott Laboratories based in Abbott Park, Ill., is receiving more than $19.5 million for the development of diagnostic biomarkers and assays for traumatic brain injury (TBI), the U.S. Department of Defense announced Aug. 13.

The contract covers research for a test that can identify mild TBI. Such a test would be based on assays compatible with a device already in use in the military health system. According to the contract, Abbott was the only bid for the job.

The research is set to be carried out in Princeton, N.J., Ottawa, Canada, and Chicago, and is expected to continue until August 2016. A total of $3,892,851 in funds have already been released for fiscal 2014 research and development.

 

Kathy Mahdoubi

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.